These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 37026252)

  • 1. Ion channels in dry eye disease.
    Ashok N; Khamar P; D'Souza S; Gijs M; Ghosh A; Sethu S; Shetty R
    Indian J Ophthalmol; 2023 Apr; 71(4):1215-1226. PubMed ID: 37026252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining Dry Eye from a Clinical Perspective.
    Tsubota K; Pflugfelder SC; Liu Z; Baudouin C; Kim HM; Messmer EM; Kruse F; Liang L; Carreno-Galeano JT; Rolando M; Yokoi N; Kinoshita S; Dana R
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Molecular Mechanisms Responsible for Tear Hyperosmolarity-Induced Pathological Changes in the Eyes of Dry Eye Disease Patients.
    Harrell CR; Feulner L; Djonov V; Pavlovic D; Volarevic V
    Cells; 2023 Dec; 12(23):. PubMed ID: 38067183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capsazepine decreases corneal pain syndrome in severe dry eye disease.
    Fakih D; Guerrero-Moreno A; Baudouin C; Réaux-Le Goazigo A; Parsadaniantz SM
    J Neuroinflammation; 2021 May; 18(1):111. PubMed ID: 33975636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulated Tear Fluid Nociception-Associated Factors, Corneal Dendritic Cell Density, and Vitamin D Levels in Evaporative Dry Eye.
    Khamar P; Nair AP; Shetty R; Vaidya T; Subramani M; Ponnalagu M; Dhamodaran K; D'souza S; Ghosh A; Pahuja N; Deshmukh R; Ahuja P; Sainani K; Nuijts RMMA; Das D; Ghosh A; Sethu S
    Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2532-2542. PubMed ID: 31195410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient tear hyperosmolarity disrupts the neuroimmune homeostasis of the ocular surface and facilitates dry eye onset.
    Guzmán M; Miglio M; Keitelman I; Shiromizu CM; Sabbione F; Fuentes F; Trevani AS; Giordano MN; Galletti JG
    Immunology; 2020 Oct; 161(2):148-161. PubMed ID: 32702135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definition and Diagnostic Criteria of Dry Eye Disease: Historical Overview and Future Directions.
    Shimazaki J
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES7-DES12. PubMed ID: 30481800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Immunological Basis of Dry Eye Disease and Current Topical Treatment Options.
    Periman LM; Perez VL; Saban DR; Lin MC; Neri P
    J Ocul Pharmacol Ther; 2020 Apr; 36(3):137-146. PubMed ID: 32175799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Video display terminal use and dry eye: preventive measures and future perspectives.
    Kamøy B; Magno M; Nøland ST; Moe MC; Petrovski G; Vehof J; Utheim TP
    Acta Ophthalmol; 2022 Nov; 100(7):723-739. PubMed ID: 35122403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular Surface Ion Transport and Dry Eye Disease.
    Lindgren ES; Cil O; Verkman AS; Pasricha ND
    Curr Ophthalmol Rep; 2022 Dec; 10(4):188-197. PubMed ID: 38213468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRPV1 in Dry Eye Disease.
    Gou Q; Song Z; Gong Y; Li J
    Front Biosci (Landmark Ed); 2024 May; 29(5):175. PubMed ID: 38812310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tear Proteomics Study of Dry Eye Disease: Which Eye Do You Adopt as the Representative Eye for the Study?
    Kuo MT; Fang PC; Kuo SF; Chen A; Huang YT
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33401599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteoglycan 4 (PRG4) expression and function in dry eye associated inflammation.
    Menon NG; Goyal R; Lema C; Woods PS; Tanguay AP; Morin AA; Das N; Jay GD; Krawetz RJ; Dufour A; Shapiro LH; Redfern RL; Ghosh M; Schmidt TA
    Exp Eye Res; 2021 Jul; 208():108628. PubMed ID: 34048779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of mucin levels at the ocular surface of visual display terminal users with and without dry eye disease.
    Duan H; Yang T; Zhou Y; Ma B; Zhao L; Chen J; Qi H
    BMC Ophthalmol; 2023 Apr; 23(1):189. PubMed ID: 37106448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contact lens to measure individual ion concentrations in tears and applications to dry eye disease.
    Badugu R; Jeng BH; Reece EA; Lakowicz JR
    Anal Biochem; 2018 Feb; 542():84-94. PubMed ID: 29183834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NLRP3 Inflammasome as a Potential Therapeutic Target in Dry Eye Disease.
    Zhuang D; Misra SL; Mugisho OO; Rupenthal ID; Craig JP
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tear Proteomics Approach to Monitoring Sjögren Syndrome or Dry Eye Disease.
    Kuo MT; Fang PC; Chao TL; Chen A; Lai YH; Huang YT; Tseng CY
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Natural History of Dry Eye Disease from the Patient's Perspective.
    Lienert JP; Tarko L; Uchino M; Christen WG; Schaumberg DA
    Ophthalmology; 2016 Feb; 123(2):425-433. PubMed ID: 26610720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel TRPM8 agonist relieves dry eye discomfort.
    Yang JM; Li F; Liu Q; Rüedi M; Wei ET; Lentsman M; Lee HS; Choi W; Kim SJ; Yoon KC
    BMC Ophthalmol; 2017 Jun; 17(1):101. PubMed ID: 28651550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A distinct cytokines profile in tear film of dry eye disease (DED) patients with HIV infection.
    Agrawal R; Balne PK; Veerappan A; Au VB; Lee B; Loo E; Ghosh A; Tong L; Teoh SC; Connolly J; Tan P
    Cytokine; 2016 Dec; 88():77-84. PubMed ID: 27585367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.